taurocholic acid has been researched along with vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YD; Gao, HK; Peng, XH; Wang, C; Wang, Z; Yan, WW; Zhao, GP; Zhou, ZG | 1 |
1 other study(ies) available for taurocholic acid and vasoactive intestinal peptide, 4-chloro-phe(6)-leu(17)-
| Article | Year |
|---|---|
Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.
Topics: Acute Disease; Animals; Capillaries; Ceruletide; Cholagogues and Choleretics; Disease Models, Animal; Duodenum; Hormone Antagonists; Male; Nerve Growth Factors; Neuropeptides; Neurotransmitter Agents; Pancreas, Exocrine; Pancreatitis; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Taurocholic Acid; Vasoactive Intestinal Peptide | 2005 |